Clinicians & hospitals

Create a precision medicine
center of excellence

Data can change how your organization approaches healthcare. Improve clinical decisions by harnessing molecular data – and become a key player in precision medicine.

Pharma & Biotech

Improve the prediction of drug
outcomes and pick the winners

With increasing health issues all over the world and the need for faster and cheaper drug development, it is necessary to start leveraging the vast data ocean of life sciences. Bringing together AI with predictive analytics and real-world data (RWD) is where it might be game changing: Predicting the success of clinical trials can redirect the focus of pharma and biotech companies onto compounds with the most potential, bringing drugs faster to the patients who need them.

Highlights

Press release 02.03.21

Molecular Health to collaborate with FALCO biosystems

Molecular Health GmbH announced today that it has entered into an agreement with Kyoto-based FALCO biosystems Ltd. to provide
genetic analysis services using MH Guide/BRCA and
MH Guide/Mendel.

Press release 27.07.20

Molecular Health and CENTOGENE Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs

The combination of real-life data sets in rare diseases with innovative big data/artificial intelligence/novel scientific computational knowledge will transform biomedical research, product development, and therapy.

Publications 04.06.20

Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide

BRCA1/2 variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition.

Activity

Klicken Sie auf den unteren Button, um den Inhalt von www.linkedin.com zu laden.

Inhalt laden

Dataome - the world’s biomedical data: integrated, cleaned and curated

The best actions are based on insight. At the center of insight is MOLECULAR HEALTH DATAOME. Built and constructed over a decade, our DATAOME TECHNOLOGY enables the quality-controlled capture, integration and analysis of clinical and molecular knowledge. By connecting real-world patient outcome data to the real-time state of clinical and molecular knowledge, MOLECULAR HEALTH DATAOME provides an unparalleled evidence base upon which decision support solutions for the healthcare industry are built.

Dataome - the world’s biomedical data: integrated, cleaned and curated

The best actions are based on insight. At the center of insight is Dataome. Built and constructed over a decade, our DATAOME TECHNOLOGY enables the quality-controlled capture, integration and analysis of clinical and molecular knowledge. By connecting real-world patient outcome data to the real-time state of clinical and molecular knowledge, Dataome provides an unparalleled evidence base upon which decision support solutions for the healthcare industry are built.

Dataome - the world’s medical data, cleaned and curated

Gaining insights has never been easier

MOLECULAR HEALTH DATAOME has become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single point of access to the world’s biomedical knowledge through our decision support applications.

Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.

Molecular Health Guide Mendel (MH Mendel) supports human geneticists in diagnosing hereditary diseases and creating diagnostic reports for individuals. The germline data analysis follows official genetic guidelines and uses the latest, world known ACMG variant classification criteria.

Molecular Health Guide (MH Guide) identifies safe and effective medication for cancer patients by analyzing the cancer’s molecular profile. It matches detected tumor mutations to the world’s knowledge in the field of oncology and helps medical experts to create a patient-specific clinical report with treatment recommendations.

Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants for hereditary breast and ovarian cancer. It creates individual patient reports based on NGS data from BRCA1/BRCA2 and other associated genes following official genetic guidelines.

You’re in good company

Molecular Health’s growing number of customers and partnerships include some of the best hospitals, laboratories, universities, and genetic facilities in the world.